+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term costs of colorectal cancer treatment in Spain



Long-term costs of colorectal cancer treatment in Spain



Bmc Health Services Research 16: 56



Assessing the long-term cost of colorectal cancer (CRC) increases our understanding of the disease burden. The aim of this paper is to estimate the long-term costs of CRC care by stage at diagnosis and phase of care in the Spanish National Health Service. Retrospective study on resource use and direct medical cost of a cohort of 699 patients diagnosed and treated for CRC in 2000-2006, with follow-up until 30 June 2011, at Hospital del Mar (Barcelona). The Kaplan-Meier sample average estimator was used to calculate observed 11-year costs, which were then extrapolated to 16 years. Bootstrap percentile confidence intervals were calculated for the mean long-term cost per patient by stage. Phase-specific, long-term costs for the entire CRC cohort were also estimated. With regard to stage at diagnosis, the mean long-term cost per patient ranged from €20,708 (in situ) to €47,681 (stage III). The estimated costs increased at more advanced stages up to stage III and then substantially decreased in stage IV. In terms of treatment phase, the mean cost of the initial period represented 24.8 % of the total mean long-term cost, whereas the cost of continuing and advanced care phases represented 16.9 and 58.3 %, respectively. This study is the first to provide long-term cost estimates for CRC treatment, by stage at diagnosis and phase of care, based on data from clinical practice in Spain, and it will contribute useful information for future studies on cost-effectiveness and budget impact of different therapeutic innovations in Spain.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058233391

Download citation: RISBibTeXText

PMID: 26883013

DOI: 10.1186/s12913-016-1297-6


Related references

Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. European Journal of Gastroenterology and Hepatology 8(12): 1179-1183, 1996

Quantifying fatigue in (long-term) colorectal cancer survivors: a study from the population-based patient reported outcomes following initial treatment and long term evaluation of survivorship registry. European Journal of Cancer 49(8): 1957-1966, 2013

Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Medical Care 37(12): 1249-1259, 1999

Colorectal Cancer and Long-Term Exposure to Trihalomethanes in Drinking Water: A Multicenter Case-Control Study in Spain and Italy. Environmental Health Perspectives 125(1): 56-65, 2017

How does initial treatment choice affect short-term and long-term costs for clinically localized prostate cancer?. Cancer 116(23): 5391-5399, 2010

Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK. Bju International 105(1): 49-56, 2010

Estimation of hospital costs of colorectal cancer in Catalonia (Spain). Gaceta Sanitaria 29(6): 437-444, 2017

Long-term treatment of metastatic colorectal cancer with panitumumab. Clinical Medicine Insights. Oncology 6: 125-135, 2012

Long-term changes in physical capacity after colorectal cancer treatment. Journal of Geriatric Oncology 6(2): 153-164, 2015

Cancer treatment's trade-off: years of added life can have long-term costs. JAMA 294(2): 167-168, 2005

Long-term survival following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study Group Trial. Oncology 45(3): 141-143, 1988

Long-term benefits of aggressive treatment for primary colorectal cancer. Journal of Surgical Oncology 62(4): 258-266, 1996

Colorectal cancer in the elderly-surgical treatment and long-term survival. International Journal of Colorectal Disease 23(6): 601-610, 2008

Quality of Life and Mortality of Long-Term Colorectal Cancer Survivors in the Seattle Colorectal Cancer Family Registry. Plos one 11(6): E0156534, 2016

Treatment of advanced colorectal cancer with long-term continuous infusion of 5-fluorouracil. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(1): 47-52, 1994